In estrogen-receptor-positive breast cancer cells, such IGF-1R-independent actions of IGFBP-2 were found to be dependent on the presence of ERα, as silencing ERα eliminated these intrinsic effects of IGFBP-2 [19]. The gene discussed is ESR1; the disease is breast cancer.